Fortrea Holdings FTRE
NASDAQ FTRE
$20.29 +0.32 (+1.60%)
As of: Sep 17, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Cash & Current Investments came in at $168.6 million in Q2 2026, up 107.64% on a YoY basis from $81.2 million in Q2 2025, and up 14.31% quarter-over-quarter from $147.5 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Cash & Current Investments (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Cash & Current Investments for 5 consecutive years, with $168.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Current Investments rose 107.64% year-over-year to $168.6 million; the trailing twelve-month figure through Jun 2026 stood at $168.6 million (up 107.64% YoY), and the FY2025 full-year result was $174.6 million, up 47.34% from the prior year.
  • Cash & Current Investments climbed to $168.6 million in Q2 2026 per FTRE's latest filing, from $147.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $174.6 million in Q4 2025 and bottomed at $81.2 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $120.7 million across 5 years, with a median of $113.2 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Cash & Current Investments plunged 35.66% in 2025, then jumped 107.64% in 2026.
  • Over 5 years, Cash & Current Investments stood at $112.0 million in 2022, then declined by 3.04% to $108.6 million in 2023, then grew by 9.12% to $118.5 million in 2024, then soared by 47.34% to $174.6 million in 2025, then fell by 3.44% to $168.6 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $168.6 million, $147.5 million, and $174.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.08 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 502.69 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 928.39 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 192.03 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 168.60 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 425.88 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 84.54 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 4.40 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 5.47 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168.60 Mn
Mar 31, 2026 147.50 Mn
Dec 31, 2025 174.60 Mn
Sep 30, 2025 131.30 Mn
Jun 30, 2025 81.20 Mn
Mar 31, 2025 101.60 Mn
Dec 31, 2024 118.50 Mn
Sep 30, 2024 105.30 Mn
Jun 30, 2024 126.20 Mn
Mar 31, 2024 92.80 Mn
Dec 31, 2023 108.60 Mn
Sep 30, 2023 107.50 Mn
Jun 30, 2023 114.30 Mn
Dec 31, 2022 112.00 Mn